Why Join a Walking Program?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01730703|
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : April 11, 2017
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||132 participants|
|Official Title:||Why Join a Walking Program?|
|Actual Study Start Date :||February 2013|
|Primary Completion Date :||April 2013|
|Study Completion Date :||April 2013|
|Adults ages 65 and older|
- Willingness to Participate [ Time Frame: Participation in the study will include only one interview, lasting approximately 25 minutes. Willingness to participate will be assessed during this first and only interview with the participant. ]The goal of this pilot project is to examine why adults would join an incentive-based walking program. Our focus is willingness to participate. Willingness to participate is measured on a 7 point ordinal scale.
- Self explicated conjoint task [ Time Frame: Participation in the study will include only one interview, lasting approximately 25 minutes. The self explicated conjoint task will be assessed during this first and only interview with the participant. ]
This study will examine the utility or value of various potential features of an incentive-based walking program. These data will enable us to monitor and improve upon enrollment of incentive-based walking programs.
How important is this feature? How desirable is this feature?
Importance: 7 point ordered scale from "extremely" to "not at all" Desirability: 7 point from "very desirable" to "very undesirable"
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01730703
|United States, Pennsylvania|
|University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19106|
|Principal Investigator:||Jason Karlawish, MD||University of Pennsylvania|